AccessBio CareStart COVID-19 Antigen Rapid Test

The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in anterior nares swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider.

As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.

• Rapid results at 10 minutes
• No lab equipment or additional instrument required
• Anterior nares swab specimen collection
• Detects SARS-CoV-2 nucleocapsid protein antigen via a lateral flow assay
• Designated as a CLIA waived test
• Manufactured in the U.S. by a U.S. headquartered company

Kit Components

• 20 Test devices
• 20 Assay buffer
• 20 Extraction vials and caps
• 20 Specimen collection swabs
• 1 Positive and 1 negative control swabs
• 1 Instructions for Use